Isomorphic Labs secures $5B Series C to advance AI-discovered drugs into human trials
DeepMind spinout Isomorphic Labs closed a $5B funding round led by Greenoaks and Sequoia, valuing the AI drug-discovery company at $50B as it moves preclinical candidates toward clinical development.